Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
An announcement from NeuroBo Pharmaceuticals (NRBO) is now available.
NeuroBo Pharmaceuticals, Inc. has entered into an exclusive licensing agreement with MThera Pharma Co., Ltd. for the rights to NB-01, a treatment for painful diabetic neuropathy. The deal empowers MThera to conduct extensive research and potentially a Phase 3 clinical trial in the U.S. and South Korea. However, the press release also contains cautionary statements about forward-looking information, indicating that these projections are not assured and actual results could vary significantly.
Learn more about NRBO stock on TipRanks’ Stock Analysis page.
